Responder Profile to Pharmaceutical-Grade Chondroitin Sulfate: An Analysis of the CONCEPT Trial

ConclusionThe treatment of OA with CS has the highest chance of success if administered in the early stage of the disease. Further research with other clinical outcomes should be carried out prior to widespread application of these findings.Trial RegistrationClinicalTrials.gov identifier, NCT03200288.

http://link.springer.com/10.1007/s12325-020-01484-x

Source: Advances in Therapy - October 11, 2020 Category: Drugs & Pharmacology Source Type: research